Ashvattha Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$50M

Ashvattha Therapeutics develops nanomedicine therapeutics to target and reprogram activated cells in inflamed regions for precision medicine in ophthalmology, neurology, and inflammation.